法洛四联症术后患儿使用参附注射液的疗效观察

The Clinical Observation of Shengfu Injection in Children Undergoing Fallot's Tetra Radical Operation

目的:观察参附注射液对法洛四联症术后患儿临床应用疗效。方法:将法洛四联症患儿38例随机分为参附组20例,对照组18例,两组均予西医常规治疗,参附组加用参附注射液。结果:参附组患儿心功能Ⅰ级恢复时间、并发症发生率、切口拆线时间、住院平均时间均比对照组有改善和提高(P<0.05)。结论:法洛四联症术后应用参附注射液,近期内改善心功能,促进患儿术后康复,减少并发症,缩短患儿住院时间。

Objective：To Observe the clinical effects of Shengfu injection in child patients undergoing Fallot＇s tetra radical operation. Methods： 38 patients undergoing Fallot＇s tetra radical operation were randomly divided into the Shengfu injection group （20 cases） and the control group （18 cases）. We introduced conventional Western medicine treatments to these two groups, the difference between the two groups was that the Shengfu injection group was treated with Shengfu injection. Results： The recovery time of class Ⅰ cardiac function, complication rate, incision suture removal time, the average hospitalization time have obviously improved and enhanced in the Shengfu injection group than those in the control group （P 〈0.05 ）. Conclusion： Shengfu injection can improve cardiac function, promote the rehabilitation of children, reduce complications and shorten the time of staying in hospital in children patients undergoing Fallot＇s tetra radical operation.